Compass Group Canada Recognized as a Top Workplace in Canada by Great Place to Work® Institute
April 25, 2024 08:30 ET
|
Compass Group Canada
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Compass Group Canada, the country’s leading food and support service company, is proud to announce that it has been recognized as one of this year’s Best...
NetBrands Corp Announces it Filed its Application to Uplist to the OTCQB Venture Market
April 25, 2024 08:30 ET
|
NetBrands Corp
Uplist to OTCQB Venture Market
Kearny Financial Corp. Announces Third Quarter Fiscal 2024 Results and Declaration of Cash Dividend
April 25, 2024 08:30 ET
|
Kearny Bank
FAIRFIELD, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter...
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
April 25, 2024 08:30 ET
|
Veru Inc.
MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
Navitas Highlights EV High-speed Hybrid Power Semiconductor Advances in China Innovation Summit Keynote
April 25, 2024 08:30 ET
|
Navitas Semiconductor Corporation
TORRANCE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC)...
Supremex Announces Date of Its 2024 First Quarter Results Conference Call and Annual Meeting of Shareholders
April 25, 2024 08:30 ET
|
Supremex Inc
MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of...
Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
April 25, 2024 08:30 ET
|
Starton Therapeutics
Phase 1b data in the first 50% of patients reflect the responses seen in animals and may suggest superiority in both safety and efficacy when compared to oral Revlimid®Anticipate FDA alignment and...
Clinical Communication & Collaboration Market is Expected to Reach $4.8 billion | MarketsandMarkets™
April 25, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 25, 2024 (GLOBE NEWSWIRE) -- Clinical Communication & Collaboration market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion...
Phunware Sets First Quarter 2024 Earnings Call for Thursday, May 9, 2024 at 4:30 p.m. ET
April 25, 2024 08:30 ET
|
Phunware, Inc.
AUSTIN, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), the leading provider of patented wayfinding and mobile engagement solutions that enable...
Aphaia Pharma Provides Enrollment and Protocol Update for Phase 2 Trial in Individuals with Obesity
April 25, 2024 08:30 ET
|
Aphaia Pharma
Enrollment has been completed for the first two cohorts evaluating a once-daily 12g dose of its oral glucose formulation (APHD-012)The company is expanding its trial protocol to further explore the...